- Accesswire•4 days ago
NEW HAVEN, CT / ACCESSWIRE / April 20, 2017 / Precipio Diagnostics, a company harnessing the experience, knowledge and expertise of academic-level pathology to deliver diagnostic accuracy to physicians ...
- Business Wire•7 days ago
Transgenomic, Inc. today reported that it has received $1.15 million in proceeds from a note bridge financing. The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC, which is expected to close during the second quarter of 2017.
- Capital Cube•10 days ago
Categories: Yahoo FinanceGet free summary analysis Transgenomic, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Transgenomic, Inc. – Agilent Technologies, Inc. (A-US) that have also reported for this period. Highlights Gross margins narrowed from -0.57% to -13.17% compared to the same period last year, ... Read more (Read more...)
TBIO : Summary for TRANSGENOMIC INC COM USD0.01(PO - Yahoo Finance
Transgenomic, Inc. (TBIO)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.43 - 0.46|
|52 Week Range||0.15 - 1.59|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.26|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|